In colon cancer stages II and III, a high EZH2 index was significantly associated with a better RFS (Figure 3, panel A, P=0.041 by the log-rank test), and with a trend for better CSS (P=0.069). The gene discussed is EZH2; the disease is colonic neoplasm.